Navegando por Autor "Vital, Ana L. F."
Agora exibindo 1 - 1 de 1
- Resultados por página
- Opções de Ordenação
Artigo Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil(Wiley, 2018) Dourado Junior, Mário Emílio Teixeira; Fernandes, Ugor T.; Ramos, Eugênio S.; Vital, Ana L. F.; Urbano, João C. C.; Queiroz, José W.; Jeronimo, Selma M. B.; https://orcid.org/0000-0002-9462-2294Objective: The Erasmus Guillain Barre Outcome Score (EGOS) is a prognostic model that predicts the chance of being able to walk independently at 6 months after Guillain Barré syndrome (GBS). This study was conducted aiming to determine the validity of EGOS in a Brazilian population.Material and Methods: Data collected from GBS patients in Rio Grande do Norte, Brazil, were used to determine the validity of EGOS. GBS disability score was as-sessed in the second week of disease and at 6 months.Results: A total of 206 subjects were studied. The Brazilian patients were younger, with a more severe clinical presentation, with higher percentage of cranial nerve in-volvement and upper respiratory infection. There was no difference relative to sex or presence of anti- gangliosides antibodies. The demyelinating variant was more com-mon (73.9%). However, only 24% of the Brazilians with EGOS 5.5-7 were not able to walk after 6 months, compared to 52% to European Group. Nine patients (3.8%) pre-sented nodopathies, of these four had an EGOS >5, but only one of the latter group was unable to walk after 6 months of GBS.Conclusions: Erasmus Guillain Barre Outcome Score was not a good predictor for the ability to walk after 6 months of GBS in Rio Grande do Norte, Brazil. Differences could be that the Brazilian GBS were younger, or alternatively, it could be due to a different infection profile or in the incidence of nodopathies.